Rigel Pharmaceuticals, Inc. (RIGL)
Nasdaq: RIGL · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2000
Grade6.4
◀ Past 5.0● Present 7.6▶ Future 6.3
Who owns Rigel Pharmaceuticals, Inc.
As filed with the SECHolders of 5% or more
4
Soleus Capital Master Fund, L.P. holds 9.9% of Common Stock, $0.001 par value per share, as its SCHEDULE 13G/A filed Aug 13, 2026 says.
Directors and officers
12
report now, of 29 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Soleus Capital Master Fund, L.P.
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, $0.001 par value per share · 5.2% in May 7, 2026
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · 6.93% in May 15, 2026
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 17, 2025 · Common Stock · 9.9% in Feb 5, 2025
State Street Corporation
SCHEDULE 13G · filed Feb 9, 2026 · COMMON STOCK
Morgan Stanley
SCHEDULE 13G/A · filed Oct 7, 2025 · Common Stock · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
Invesco LTD
SCHEDULE 13G/A · filed Feb 7, 2025 · Common Stock · reported falling below 5%
What RIGL reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Blueprint Medicines Corporation
A company bought · asset acquisition · owns, named in the 10-K filed Mar 3, 2026
Insider tradesForm 4
3sales
0purchases
2sales on a scheduled plan
2people selling
$300,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 29 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Ali-Jackson Kamil | director | 2 | $200,000 | 2 | 0 | $0 |
| Moos Walter H | director | 1 | $100,000 | 0 | 0 | $0 |